Overview in the sources
The Drug Enforcement Administration enters these excerpts not as an institution examined on its own terms but as an actor inside a larger argument about drug prohibition. In the 2015 episode, Lucy Steigerwald names the agency in a single breath as an example of public-sector employment that exists because of over-criminalization, grouping it with the Bureau of Prisons and the prison guard unions. In the 2022 episodes, Dr. Jeffrey Singer gives the agency two concrete functions: it was created as part of President Richard Nixon’s war on drugs, and it schedules drugs and sets annual production quotas for controlled substances. The excerpts supply no founding date, no administrator, no budget, no case law, and no internal description of the agency.
Creation and scheduling
Dr. Jeffrey Singer places the DEA’s creation inside a chronology of the overdose crisis. He cites a 2019 report by the Joint Economic Committee of Congress stating that overdose rates started climbing in 1959, and says that by 1970 President Richard Nixon, alarmed at the overdose crisis, declared war on drugs — which Singer calls drug war number two. In that account, the war on drugs produced the Drug Enforcement Administration, which scheduled drugs Fresh Approaches to the Overdose Crisis (2022). Singer describes Schedule I as drugs with no medical use, naming marijuana and diamorphine, and Schedule II as drugs with medical use but high addictive potential. He notes the anomaly that morphine and fentanyl have medical use while diamorphine does not, and that LSD is placed in Schedule I.
Singer’s framing is that scheduling is a government classification rather than a medical finding. He says that everyone using marijuana knows it has no medical use according to the government — a formulation that attributes the judgment to the government rather than endorsing it.
Quotas on controlled substances
In the 2022 episode on blame for the opioid crisis, Singer describes a second DEA function: setting quotas. He says the Drug Enforcement Administration sets quotas on how much of every single category of painkiller and controlled substance — whether fentanyl, morphine or oxycodone — may be produced, and that it is charged with deciding for the next year how much of each the United States, with a population of 330 million people, will need Who’s to Blame for the Opioid Crisis? (2022). He calls this an impossible thing to figure out, and says the agency tells each company how much it can make that year.
Bob Zadek presses the implication, asking whether the limitation creates an artificial shortage by governmental action and whether removing it would diminish imported fentanyl. Singer answers no, and explains that licit fentanyl is manufactured in the United States by pharmaceutical companies for hospital use, but that illicit production moves offshore because it is easier to make cheaply and out of the view of law enforcement. He draws the parallel to methamphetamine, which he notes is a legal drug made in the United States to treat ADHD under the brand name Desoxyn, while meth labs are mostly in Mexico now — originally there were many local domestic meth labs, but it is easier to operate out of the sight of law enforcement elsewhere. In Singer’s account, then, the quota regime coexists with, rather than causes, offshore production.
The DEA in the critique of over-criminalization
Lucy Steigerwald’s reference is briefer and broader. Responding to Bob Zadek’s argument that prison guard unions, more than prison builders, profit from the deprivation of liberty, she offers the entirety of the Drug Enforcement Administration as another example, saying there are lots of people in the public sector whose jobs exist because of over-criminalization Lucy Steigerwald on The Drug War and Private Prisons (2015). She adds that she is sure Bureau of Prisons staff could be cut heavily if the war on drugs were gotten rid of.
The point in context is about incentives, not about the agency’s conduct. Steigerwald’s argument in that episode is that private prisons are not a new threat but the same old thing with different window dressing, because the perverse incentives were merely more clouded in the public sector. The DEA functions in her remarks as one more public-sector body whose livelihood depends on the policies it enforces. Bob Zadek’s own contributions in that exchange concern the California prison guards union, which he calls the most powerful public service union in the country, and which he blames for the California three strikes law and for encouraging solitary confinement because isolation requires three times the manpower.
Across episodes
The topic appears in three episodes spanning 2015 to 2022, and the treatment shifts in kind rather than in conclusion. Steigerwald in 2015 uses the DEA as an illustration of public-sector incentives under over-criminalization; Singer in 2022 supplies the institutional detail — creation under Nixon’s drug war, scheduling, and production quotas — and makes the agency a load-bearing part of his account of the overdose crisis. Both speakers oppose drug prohibition, so the excerpts show no argument between them; what changes is the level of specificity, from a passing example to a described mechanism. No excerpt shows either guest defending the agency or describing its enforcement operations.
What the sources do not cover
The excerpts do not state when the DEA was founded, who has led it, what statutes authorize it, or what its budget and staffing are. They do not describe any DEA case, raid, prosecution, or court ruling, and they do not say which amendment any enforcement practice turns on. The scheduling discussion names Schedule I and Schedule II but does not reproduce the statute or the criteria in full. Nothing in the excerpts addresses state legalization, rescheduling petitions, or the agency’s relationship to other federal bodies beyond the quota-setting function Singer describes.